Key result
Atrial leadless pacing was successfully implanted in all 10 patients, with 0 complications occurring over a mean follow-up of 3.8 months.
Why the study?
The recent availability of atrial leadless pacemakers enables a re-evaluation of AAI(R) pacing for sinus node dysfunction, aiming to assess early clinical and implant outcomes.
Does atrial leadless pacing provide safe and effective early outcomes in patients requiring atrial pacing?
Design
Observational cohort study
Follow-up
Mean 3.8 months (range 2–8 months)
Authors
Loading...
Atrial LP enables AAI pacing for SND without RV lead risks; leaves open whether it reduces complications versus DDD in prospective trials.
Observational (n=10)
Does atrial leadless pacing provide safe and effective early outcomes in patients requiring atrial pacing?
Atrial leadless pacing appears to be a safe and feasible option for patients with sinus node dysfunction, with good early device performance and no complications.
Velraeds et al. (2026) conducted an observational in Sinus node dysfunction (n=10). Atrial leadless pacemaker was evaluated on Complications. Atrial leadless pacing was successfully implanted in all 10 patients, with 0 complications occurring over a mean follow-up of 3.8 months.